Pharmaceutical Companies

RVL Pharmaceuticals plc

Country: 🇺🇸United States

Ownership: Public

Established: -

Employees: 125

Market Cap: $3.1M

Website: http://www.rvlpharma.com

RVL Pharmaceuticals plc

🇺🇸United States

Ownership: Public

Established: -

Employees: 125

Market Cap: $3.1M

Website: http://www.rvlpharma.com

Altamira Therapeutics AG

Country: 🇨🇭Switzerland

Ownership: -

Established: -

Employees: -

Market Cap: $2.9M

Website: -

Altamira Therapeutics AG

🇨🇭Switzerland

Ownership: -

Established: -

Employees: -

Market Cap: $2.9M

Website: -

Phio Pharmaceuticals

Country: 🇺🇸United States

Ownership: Public

Established: 2012-01-01

Employees: 9

Market Cap: $2.7M

Website: http://www.phiopharma.com

Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the development of immuno-oncology therapeutics. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.

Phio Pharmaceuticals

🇺🇸United States

Ownership: Public

Established: 2012-01-01

Employees: 9

Market Cap: $2.7M

Website: http://www.phiopharma.com

Quoin Pharmaceuticals

Country: 🇺🇸United States

Ownership: -

Established: -

Employees: 4

Market Cap: $2.4M

Website: -

Quoin Pharmaceuticals Ltd. engages in the development of therapeutic products for the treatment of rare and orphan diseases. Its product pipeline includes QRX003, QRX004, QRX007, and QRX008. The company was founded by Michael Myers and Denise Carter on March 5, 2018 and is headquartered in Ashburn, VA.

Quoin Pharmaceuticals

🇺🇸United States

Ownership: -

Established: -

Employees: 4

Market Cap: $2.4M

Website: -

SEELOS THERAPEUTICS INC

Country: 🇺🇸United States

Ownership: -

Established: -

Employees: -

Market Cap: $1.9M

Website: -

SEELOS THERAPEUTICS INC

🇺🇸United States

Ownership: -

Established: -

Employees: -

Market Cap: $1.9M

Website: -

PainReform

Country: 🇮🇱Israel

Ownership: Public

Established: 2007-01-01

Employees: 7

Market Cap: $1.9M

Website: http://www.painreform.com

PainReform Ltd. is a pharmaceutical company, which focuses on reformulation of established therapeutics. It offers PRF-110, an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed prior to closure to provide localized and extended post-operative analgesia. The company was founded by Lihu Avitov and Dan Teleman in 2007 and is headquartered in Herzliya, Israel.

PainReform

🇮🇱Israel

Ownership: Public

Established: 2007-01-01

Employees: 7

Market Cap: $1.9M

Website: http://www.painreform.com

Galmed Pharmaceuticals

Country: 🇮🇱Israel

Ownership: Public

Established: 2000-01-01

Employees: 8

Market Cap: $1.8M

Website: http://galmedpharma.com

Galmed Pharmaceuticals Ltd. is a clinical-stage drug development biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecule for the oral treatment of NASH in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The compa...

Galmed Pharmaceuticals

🇮🇱Israel

Ownership: Public

Established: 2000-01-01

Employees: 8

Market Cap: $1.8M

Website: http://galmedpharma.com

VBI Vaccines Inc

Country: 🇨🇦Canada

Ownership: -

Established: -

Employees: -

Market Cap: $1.8M

Website: -

VBI Vaccines Inc

🇨🇦Canada

Ownership: -

Established: -

Employees: -

Market Cap: $1.8M

Website: -

180 Life Sciences

Country: 🇺🇸United States

Ownership: Public

Established: 2013-01-01

Employees: 4

Market Cap: $1.8M

Website: http://www.180lifesciences.com

180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard ...